Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 21, 2002

View Archived Issues

New compound for toxoplasmosis requires a functional immune system

Nabi discusses development plans for 2002

Beyond Genomics and diaDexus enter cancer diagnostic and drug discovery agreement

Ono-2506 improves outcome in murine models of EAE

Improved antidiabetic and hypolipidemic activity in a series of dual PPARalpha/PPARgamma agonists

Commonly used antibiotic shows potential for Rx of multiple sclerosis

Effects of raloxifene on cardiovascular events analyzed using data from the MORE trial

AnorMED looks forward to progress in 2002

EpiDex to be regulated as a medical device in the U.S.

Preliminary results of transmissible spongiform encephalopathies diagnostic test

sNDA submitted for Prevacid in pediatric patients

Positive results from phase I trial of PT-141 in erectile dysfunction

AGIX-4207 completes phase I in rheumatoid arthritis

ImmunoGen and Millennium sign exclusive product license

Chiron completes cash tender offer for Matrix stock

ML-3000 fails to meet all efficacy endpoints in E.U. trial

Novel anticancer therapy target validated at Cell Therapeutics

Casodex 150 mg receives priority review in early-stage prostate cancer

Sucampo licenses tacrolimus from Fujisawa for ophthalmic use

DuPont scientists synthesize compounds with CRF-antagonist activity

Compounds with myocardial electrophysiological activity claimed by AstraZeneca

Akzo Nobel identifies aminoisoquinoline-containing compounds effective as thrombin inhibitors

Inhibitors of cyclin-dependent kinases with potential as antitumor agents

Taisho compounds show utility in CRF-mediated conditions

Recent patent covers Boehringer Ingelheim compounds useful for the treatment of HCV infection

Scientists at Nikken Chemicals prepare adenosine derivatives with antihyperlipidemic activity

FDA Science Forum to be broadcast by Prous Science

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...